ResMed (RMD) Stock Forecast & Price Target

$162.87

-0.62 (-0.38%)

(As of 12/8/2023 ET)

Today's Range: $162.48
▼
$163.93
50-Day Range: $134.74
▼
$164.00
52-Week Range: $132.24
▼
$243.52

Volume: 763,229 shs
Average Volume: 976,053 shs
Market Capitalization: $23.96 billion

P/E Ratio: 26.44
Dividend Yield: 1.18%
Price Target: $202.33

ResMed Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 12 Analyst Ratings

Analysts' Consensus Price Target

$202.33
24.23% Upside

High Forecast	$290.00
Average Forecast	$202.33
Low Forecast	$160.00

Type	Current Forecast 12/9/22 to 12/9/23	1 Month Ago 11/9/22 to 11/9/23	3 Months Ago 9/10/22 to 9/10/23	1 Year Ago 12/9/21 to 12/9/22
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	9 Buy rating(s)	8 Buy rating(s)	5 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$202.33	$202.33	$261.86	$267.00
Predicted Upside	24.23% Upside	28.39% Upside	21.03% Upside	17.36% Upside

Get ResMed Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter.

RMD Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

RMD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ResMed Stock vs. The Competition

Type	ResMed	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.67	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	24.29% Upside	734.75% Upside	3,819.09% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/31/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$180.00 ➝ $160.00	+16.41%
10/27/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$180.00 ➝ $169.00	+21.82%
10/16/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$275.00 ➝ $175.00	+24.81%
10/12/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Sector Perform	$273.00 ➝ $202.00	+40.05%
10/9/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Overweight	$210.00 ➝ $170.00	+16.49%
10/5/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$240.00 ➝ $165.00	+11.49%
9/29/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Peer Perform
9/18/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$250.00 ➝ $230.00	+56.36%
9/6/2023	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
9/5/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
8/4/2023	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$280.00 ➝ $260.00	+18.21%
1/31/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kaczor Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
1/18/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:04 AM ET.

RMD Price Target - Frequently Asked Questions

What is ResMed's consensus rating and price target?: According to the issued ratings of 12 analysts in the last year, the consensus rating for ResMed stock is Moderate Buy based on the current 3 hold ratings and 9 buy ratings for RMD. The average twelve-month price prediction for ResMed is $202.33 with a high price target of $290.00 and a low price target of $160.00. Learn more on RMD's analyst rating history.
Do Wall Street analysts like ResMed more than its competitors?: Analysts like ResMed more than other Medical companies. The consensus rating score for ResMed is 2.75 while the average consensus rating score for medical companies is 2.68. Learn more on how RMD compares to other companies.
Is ResMed being upgraded or downgraded by Wall Street analysts?: Over the previous 90 days, ResMed's stock had 2 upgrades and 2 downgrades by analysts.

Does ResMed's stock price have much upside?: According to analysts, ResMed's stock has a predicted upside of 28.39% based on their 12-month stock forecasts.
What analysts cover ResMed?: ResMed has been rated by Bank of America, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Oppenheimer, Royal Bank of Canada, and Wolfe Research in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NYSE:RMD) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial